Bedfordshire and Luton Joint Prescribing Committee
Ref: JPC Bulletin 261
Bulletin Date: 01/03/18
Review Date: March 2021
Bulletin 261 : Tolvaptan (Samsca® Brand) tablets for the treatment of hyponatraemia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients not requiring chemotherapy
To support the East of England Priorities Advisory Committee (PAC) Guidance and recommendations (See attached EoEPAC bulletin) with the additional caveat that ‘secondary care’ (referred to in the EoEPAC recommendations) includes hospices.